February 24, 2010 (FinancialWire) — Solta Medical, Inc. (NASDAQ: SLTM), a company engaged in the medical aesthetics market, said it has entered into a definitive agreement to acquire privately-held Aesthera Corp. for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6 million.

In addition, the deal calls for $10 million of stretch milestones to be paid to Aesthera shareholders if Aesthera achieves revenue ranging from $14 to $21 million in the twelve months beginning April 1, 2010.

Solta said it expects that the transaction will be accretive to its earnings within twelve months, excluding acquisition and integration related charges.

It added that the proposed transaction becomes increasingly accretive to Solta Medical shareholders as Aesthera achieves the higher milestone revenue and payments.

California-based Aesthera’s unaudited revenue for the twelve months ended December 31, 2009 was approximately $8.5 million. Solta Medical said it expects to close the transaction prior to March 31.

Aesthera’s makes light based devices with FDA marketing clearance for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne.

California-based Solta Medical offers products to address aging skin under two brands: Thermage and Fraxel. Thermage is a non-invasive radiofrequency procedure for tightening and contouring skin. Fraxel offers minimally invasive clinical solutions to resurface aging and sun damaged skin.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.